About MapLight Therapeutics
MapLight Therapeutics is a private company based in Redwood City, California. It has reported $356,187,906 raised in six offerings on Form D since March 2019. Its chief executive is Christopher Kroeger.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 18, 2025 | Jul 28, 2025 | $188,187,915of $372.4M target | 19 | $9.9M | EquityRule 506(b) | Form D ↗ |
| Jul 5, 2023 | Jul 19, 2023amended Nov 3, 2023 | $104,999,994of $224.9M target | 12 | $8.7M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Oct 25, 2022 | Nov 10, 2022 | $11,999,999fully sold | 1 | $11.9M | Equity, The underlying shares of common stock issuable upon conversion.Rule 506(b) | Form D ↗ |
| Feb 23, 2021 | Mar 10, 2021 | $29,999,999of $59.9M target | 2 | $14.9M | Equity, The underlying shares of common stock issuable upon conversion.Rule 506(b) | Form D ↗ |
| Aug 23, 2019 | Sep 4, 2019 | $15,999,999fully sold | 2 | $7.9M | Equity, The underlying shares of common stock issuable upon conversion.Rule 506(b) | Form D ↗ |
| Feb 22, 2019 | Mar 8, 2019amended Mar 22, 2019 | $5,000,000fully sold | 2 | $2.5M | Equity, The underlying shares of common stock issuable upon conversion.Rule 506(b) | Form D/A ↗1 earlier filing |
| Total, six offerings | $356,187,906 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on MapLight Therapeutics's Form D filed Jul 28, 2025.
KH
Kristopher Hanson
Executive officer
TG
Timothy Garnett
Director
GP
George Pavlov
Director
PB
Peter Bisgaard
Director
EF
Erin Foff
Executive officer
AK
Anatol Kreitzer
Executive officer
JT
Jim Trenkle
Director
JL
James Lillie
Executive officer
MW
Maria Walker
Director
CK
Christopher Kroeger
Chief Executive Officer and director
JG
Jonathan Gillis
Executive officer
VS
Vishwas Setia
Executive officer
NL
Nanna Luneborg
Director
Earlier filings also listed Robert Malenka (director, last listed Nov 2023) and Charmaine Lykins (executive officer, last listed Nov 2023).